Thanks, FL. I’m waiting for someone to try to explain the factoid (mentioned in #msg-64637084) that drugs developed in-house by Big Pharma are 20% more likely to obtain regulatory approval than those that are in-licensed.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”